EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

2020 Annals of the Rheumatic Diseases 2,587 citations

Keywords

MedicineAntirheumatic drugsRheumatoid arthritisAntirheumatic AgentsDisease managementIntensive care medicineArthritisDiseaseBiological drugsPhysical therapyInternal medicine

Affiliated Institutions

Related Publications

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Background and Purpose— The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations in a single document for clinicians caring for adult pat...

2019 Stroke 6607 citations

Publication Info

Year
2020
Type
article
Volume
79
Issue
6
Pages
685-699
Citations
2587
Access
Closed

External Links

Citation Metrics

2587
OpenAlex

Cite This

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. (2020). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases , 79 (6) , 685-699. https://doi.org/10.1136/annrheumdis-2019-216655

Identifiers

DOI
10.1136/annrheumdis-2019-216655